South African Pharmaceutical Journal: Volume 91, Number 6, November/December 2024

Introduction

This journal package grants pharmacists and healthcare professionals access to the November / December 2024 issue of the South African Pharmaceutical Journal, including a quiz to test knowledge gained and receive a certificate if completed successfully.

The journal provides specific clinical reviews on self-medication topics (symptomatic therapy), information on prescription medication (therapy in clinical context) and provides the pharmacists with essential information for referring customers for early medical attention should it be required. Pharmacovigilance – ensuring the safe and appropriate administration and use of medication and reporting of serious adverse events or other adverse drug reactions – is strongly advocated in SAPJ. The SAPJ further supports pharmacists to transform the pharmacy in an accessible, basic primary health care facility for preventing and treating PHC conditions through diagnosis, screening and treatment.

Who Should Enrol

Course Content

Course Lessons

Certification

The assessment (MCQ) must be successfully completed to receive your certificate - two (2) attempts to achieve 70%.

The quiz is based on the following three (3) articles:

Evaluation of the labelling adherence of the food-associated effects of selected pharmacotherapy
Mental health update – Update on depression with a focus on vortioxetine
Semaglutide (Ozempic®): A comprehensive review of its pharmacology, efficacy, and safety profile in type 2 diabetes mellitus and weight management

Surgipharm Nivina Towers, 71 Westlands Roads
Phone number: +254 20 374 9304 / +254 20 374 9306